# Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

> **NCT04793932** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Associazione Italiana per lo Studio del Pancreas** · enrollment: 261 (actual)

## Conditions studied

- Pancreas Ductal Adenocarcinoma

## Interventions

- **DRUG:** PAXG
- **DRUG:** mFOLFIRINOX
- **DRUG:** short-course chemotherapy
- **DRUG:** long-course chemotherapy

## Key facts

- **NCT ID:** NCT04793932
- **Lead sponsor:** Associazione Italiana per lo Studio del Pancreas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-03
- **Primary completion:** 2025-03-15
- **Final completion:** 2026-01-31
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04793932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04793932, "Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04793932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*